Valued at USD 2.1 Billion in 2023, Digital Pathology Market to Grow at 8.5% CAGR in the Coming Years (2024-30)

In a latest report published by MarkNtel Advisors, it was highlighted that the Global Digital Pathology Market size was valued at around USD 2.1 billion in 2023 and is predicted to grow at a CAGR of about 8.5% during the forecast period, i.e., 2024-30. The extensive usage of digital pathology in the healthcare sector to accurately diagnose the illness related to any particular medical issues coupled with its wide-ranging usage in medical schools for teaching purposes are the two major factors leading to the growth of the Global Digital Pathology Market.

The report highlights several factors that are expected to drive the Global Digital Pathology Market upward in the forecast period. These factors include the rising prevalence of both communicable and non-communicable diseases, unhealthy lifestyles, growing population, and widespread tobacco use. Also, digital pathology is crucial in ensuring fast and accurate diagnosis of various complications and health issues, further propelling the market growth.

Get a Free Sample Report: https://www.marknteladvisors.com/query/request-sample/digital-pathology-market-report.html

In terms of region, the Global Digital Pathology Market is likely to be dominated by North America in the forecast period owing to the massive amount of investments made in the medical and healthcare industry in countries like the US, Canada, and Mexico.

Companies Holding a Substantial Share in the Global Digital Pathology Market

3Dhistech Ltd., Apollo Enterprise Imaging Corp, Aurora Interactive Ltd., Koninklijke Philips, Corista Llc, Glencoe Software, Inc., Definiens Ag, F. Hoffmann-La Roche Ltd., Digipath Inc., Huron Technologies International Inc., Indica Labs Inc., Leica Biosystem Inc., Omnyx Llc, Ligolab Llc, Mikroscan Technologies Inc. and others.

Read Full Report: https://www.marknteladvisors.com/research-library/digital-pathology-market-report.html

Analyzing the Segmentation of the Global Digital Pathology Market

  • By Component (Software, Service, Hardware (Digital Camera Scanner, Communication System, Storage System, and Others (Information Management Systems, robotic microscopes, other diagnostic devices, etc.)))
  • By Application (Clinical Pathology, Teleconsultation, Molecular Diagnostics, Basic & Applied Research, Drug Development, and Others (Training & Education, etc.))
  • By Technology (Whole Slide Imaging, Image Analysis Software, Storage, Communication Data, and Others)
  • By Type (Genetic Pathology, Hematology and Clinical Pathology, Immunopathology, Chemical Pathology, Forensic Pathology, and Microbiology)
  • By End User (Biotech & Pharma Company, Hospitals, Diagnostic Centers, and Others (Academic & Research Institutes))
  • By Region (North America, South America, Europe, The Middle East & Africa, and Asia-Pacific)

Hardware-based digital pathology solutions observed a decent growth in demand in the present years. The demand for hardware-based solutions across the Digital Pathology Market is boosted due to the escalating sales of digital cameras, scanners, and communication systems amid numerous end-users such as healthcare institutions, pharma & biopharma companies, etc. Hardware-based digital pathology solutions are used to transfer the taken sample pictures from one device to another without compromising their quality or features.

Telemedicine has Opened New Opportunistic Avenues in the Global Digital Pathology Market

Telemedicine is creating new opportunities for growth in Digital Pathology Market owing to its characteristic of connecting patients with doctors or healthcare professionals in remote locations. The smooth incorporation of digital pathology with telemedicine enables the assessment and diagnosis of problems remotely and ensures the reach of healthcare facilities in remote or interior areas with restricted access to medical experts. This incorporation and integration of telemedicine with the digital pathology market leads to the upgradation of medical facilities, providing substantial opportunities for providers, further boosting the Global Digital Pathology Market in the forecast years.

About Us:

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Media Representative

Company Name: MarkNtel Advisors

Email: sales@marknteladvisors.com

Phone: +1 628 895 8081 +91 120 4268433,         

Address: 564 Prospect St, B9, New Haven, Connecticut, USA-06511

Participe da discussão

Compare listings

Comparar